Behind the Breakthroughs - New Hope New Options for Lymphoid and Myeloid Blood Cancers

Join us on October 11 to learn about Dana-Farber’s leadership in drug development and how your support plays a vital role in moving an idea from research to patient care. Leaders in hematologic oncology will describe venetoclax – the first in a new class of drugs and one of the greatest breakthroughs in recent years – and its impact on patients across several blood cancer types. This complimentary educational webinar will include a live, interactive session for your questions. Register to attend.

Go to Event Web Page